Quarterly report pursuant to Section 13 or 15(d)

Share-Based Expense

Share-Based Expense

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

7.	Share-Based Expense

Total share-based expense related to stock options and restricted stock units (“RSUs”) was approximately $0.1 million during each of the three months ended March 31, 2023 and 2022.

Share-based expense is classified in the condensed consolidated statements of operations as follows:


	Three Months Ended March 31,
	2023		2022
Research and development expenses	$	13,688	$	19,178
General and administrative expenses		55,164		100,417
	$	68,852	$	119,595

Employee Stock Options

No stock option awards to purchase shares of common stock were granted during the three months ended March 31, 2023. During the three months ended March 31, 2022, the Company granted 200,000 stock option awards to purchase shares of common stock. The Company recognized a total of approximately $0.1 million of compensation expense related to employee stock options during each of the three months ended March 31, 2023 and 2022. No employee stock options or RSUs were exercised and none expired during the three months ended March 31, 2023 and 2022.

Non-Employee Stock Options

There were no non-employee stock options granted or exercised during the three months ended March 31, 2023 and 2022, respectively. During the three months ended March 31, 2023, non-employee stock option grants to purchase approximately 1,000 shares of common stock expired. No non-employee stock option grants expired during the three months ended March 31, 2022. The Company did not recognize any expense related to non-employee stock options during the three months ended March 31, 2023 and 2022, respectively.